English Precision-Fermented All-Trans Menaquinone-7 (MK-7) • SGS-Verified Cleanroom Extraction • Resilient Supply Chains & Danube Multi-Modal Logistics into Odesa and Greater Ukraine
Supplied under strict ISO 22000, HACCP, and GMP standards with direct maritime and overland cold-chain documentation for Ukraine's compounding pharmacies and dietary supplement brands.
Vitamin K2 (menaquinone) functions as an indispensable enzymatic co-factor for the gamma-glutamyl carboxylase (GGCX) enzyme, facilitating the carboxylation of vitamin K-dependent proteins: Osteocalcin (bone Gla protein) and Matrix Gla Protein (MGP). For formulators in Odesa and throughout Ukraine's pharmaceutical corridor, distinguishing between short-chain synthetic homologues such as Menadione derivatives or Menatetrenone (MK-4) and bio-fermented long-chain Menaquinone-7 (MK-7) is critical for clinical efficacy and therapeutic bioavailability.
BKYULA Biotech manufactures natural Menaquinone-7 via deep-tank submerged aerobic fermentation employing non-GMO Bacillus subtilis natto. Unlike synthetic stereoisomers that yield inactive cis-isomers, our solvent-free, supercritical CO2 crystal purification produces exceeding 99% pure all-trans MK-7. All-trans MK-7 provides an extraordinary in-vivo plasma half-life of roughly 72 hours, contrasted sharply with the 1.5-hour clearance window of MK-4. This sustained circulation guarantees optimal extra-hepatic tissue uptake—predominantly in cortical and trabecular bone matrices as well as the medial elastic layer of human arterial walls.
Our pharmaceutical-grade MK-7 crystals and microencapsulated beadlets (ranging in assays from 1,000 ppm, 2,000 ppm, 5,000 ppm up to 98% pure HPLC crystalline powder) undergo dual validation. Every batch released to our Eastern European trade lanes includes quantitative HPLC chiral chromatography profiles, confirming zero presence of inactive cis-conformations that fail European Food Safety Authority (EFSA) biological equivalence metrics.
Odesa stands as the pivotal commercial gateway of Southern Ukraine, anchored by its extensive maritime traditions, advanced clinical universities, and expanding localized pharmaceutical processing. Formulators operating within the Odesa Oblast, along with nearby production hubs in Chornomorsk and Yuzhne, require specialized, climate-stabilized nutritional actives tailored to distinct domestic demographic pressures and health priorities.
Southern Ukraine's aging demographic requires therapeutic calcium-directing agents. By pairing BKYULA Vitamin K2 MK7 with micro-encapsulated Vitamin D3 (Cholecalciferol 100,000 IU/g), local compounding plants produce dual-action tablets that steer ionic calcium directly into hydroxyapatite crystals while preventing iatrogenic hypercalcemia.
Given the documented prevalence of ischemic cardiopathies in the Black Sea zone, Odesa nutraceutical formulators are integrating microencapsulated MK-7 into cardioprotective softgels. Activated Matrix Gla Protein (MGP) actively halts hydroxyapatite precipitation along vascular smooth muscle layers, directly mitigating arterial stiffness.
Odesa's extensive livestock and poultry farms utilize FAMI-QS certified Vitamin K2 premixes to support accelerated ossification in poultry broilers, reduce tibial dyschondroplasia, and dramatically improve eggshell membrane strength under industrial humid maritime conditions.
The Ukrainian regulatory landscape for dietary ingredients and food fortification is undergoing accelerated convergence with the European Union acquis communautaire, notably Directive 2002/46/EC and Regulation (EC) No 1924/2006 on health claims. Consequently, Odesa procurement managers are systematically moving away from unverified suppliers toward verified primary factories capable of delivering full traceability, zero cross-contamination documentation, and full elemental impurity dossiers under ICH Q3D.
Standard uncoated Vitamin K2 MK-7 degrades rapidly in the presence of alkaline mineral salts like Calcium Carbonate, Calcium Citrate, or Magnesium Oxide. Direct contact triggers cleavage of the polyisoprene side-chain within weeks in standard shelf-life testing. To solve this, BKYULA Biotech engineers double-coated microencapsulated beadlets utilizing water-soluble plant starches and antioxidant lipid envelopes. This state-of-the-art matrix shields the fragile menaquinone molecule, delivering a validated 36-month shelf stability even in high-moisture maritime storage conditions typical of Odesa's port facilities.
In response to evolving shipping conditions across the Black Sea, BKYULA Biotech has established uninterrupted logistics pipelines serving Odesa buyers. Working in conjunction with multimodal routes via Constanța (Romania), Gdańsk (Poland), and Danube inland water transport (Izmail and Reni ports), we execute shipments under flexible Incoterms (CIF Odesa, CIP Chișinău, or DDP direct to Odesa pharmaceutical warehouses). We guarantee temperature-monitored, moisture-barrier packaging to ensure zero quality degradation during cross-border transit.
Operating from our primary production center in Xi'an, Shaanxi, China, BKYULA Biotech Co., Ltd. combines nearly 15 years of industrial extraction mastery with verified trade capacity. As an SGS onsite-inspected primary source, we provide institutional purchasers in Odesa with total batch consistency, direct factory-gate pricing, and transparent laboratory validation.
Multi-stage stainless extraction, multi-tier ultrafiltration, and low-temperature vacuum crystallization protect heat-labile actives.
Every lot is quantified for isomeric purity, residual solvents, heavy metals (ICP-MS), and microbiological pathogen absence.
Certified under ISO 9001:2015, ISO 22000, HACCP, HALAL, KOSHER, and FAMI-QS for regulatory clearance in Ukraine.
Connect immediately with our technical export division. Obtain batch-specific COAs, chiral HPLC chromatograms, regulatory validation packages, and rapid CIF/CIP pricing to Odesa.